Propolis Skin Randomized Trial: What the Evidence Says

Quick Answer

Propolis Skin Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• The risk of dental caries increases with the continuous consumption of carbohydrates and sugar, resulting in increased acidity and disruption of the oral microbial balance. [Irmaleny Irmaleny (2026); evidence level 3]
• However, CPP-ACP has a drawback-it poses a high risk for lactose-intolerant individuals and is expensive. [Irmaleny Irmaleny (2026); evidence level 3]
• Critically, senescent cells adopt a pro-inflammatory Senescence-Associated Secretory Phenotype (SASP), secreting cytokines (IL-6, IL-8), chemokines, and matrix metalloproteinases (MMPs) that drive chronic low-grade inflammation ("inflammaging") and extracellular matrix degradation. [Radić Božo (2026); evidence level 4]
• This study provides the first evidence that a chemically defined, standardized propolis extract acts as a senomorphic agent in human dermal fibroblasts. [Radić Božo (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For propolis skin randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Irmaleny Irmaleny (2026). The Potential of Aloe vera as a Caries Prevention Agent in the Future: A Scoping Review. DOI: 10.3390/jcm15124744. PMCID: PMC13302088. PMID: 42355912. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13302088/
• Radić Božo (2026). Senomorphic Activity of a Novel Standardized Propolis Extract in Human Dermal Fibroblasts: Molecular Insights Into Clinically Proven Anti‐Wrinkle Efficacy. DOI: 10.1111/jocd.70689. PMCID: PMC13002322. PMID: 41856779. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13002322/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.